NorandrostenedioneCAS# 734-32-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 734-32-7 | SDF | Download SDF |
| PubChem ID | 92834 | Appearance | Powder |
| Formula | C18H24O2 | M.Wt | 272.4 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (8R,9S,10R,13S,14S)-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione | ||
| SMILES | CC12CCC3C(C1CCC2=O)CCC4=CC(=O)CCC34 | ||
| Standard InChIKey | JRIZOGLBRPZBLQ-QXUSFIETSA-N | ||
| Standard InChI | InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-16H,2-9H2,1H3/t13-,14+,15+,16-,18-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Norandrostenedione Dilution Calculator
Norandrostenedione Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.6711 mL | 18.3554 mL | 36.7107 mL | 73.4214 mL | 91.7768 mL |
| 5 mM | 0.7342 mL | 3.6711 mL | 7.3421 mL | 14.6843 mL | 18.3554 mL |
| 10 mM | 0.3671 mL | 1.8355 mL | 3.6711 mL | 7.3421 mL | 9.1777 mL |
| 50 mM | 0.0734 mL | 0.3671 mL | 0.7342 mL | 1.4684 mL | 1.8355 mL |
| 100 mM | 0.0367 mL | 0.1836 mL | 0.3671 mL | 0.7342 mL | 0.9178 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- AR 231453
Catalog No.:BCC5143
CAS No.:733750-99-7
- SB 706375
Catalog No.:BCC6256
CAS No.:733734-61-7
- SCH 50911
Catalog No.:BCC5692
CAS No.:733717-87-8
- Niclosamide monohydrate
Catalog No.:BCC5212
CAS No.:73360-56-2
- 9-O-Acetyl-4,4'-di-O-methyllariciresinol
Catalog No.:BCN1367
CAS No.:73354-15-1
- Albanin A
Catalog No.:BCN3290
CAS No.:73343-42-7
- Macbecin I
Catalog No.:BCC7551
CAS No.:73341-72-7
- 3-Hydroxy-9,10-Dimethoxypterocarpan
Catalog No.:BCC8101
CAS No.:73340-41-7
- Methylnissolin
Catalog No.:BCN1368
CAS No.:733-40-4
- BAY 61-3606
Catalog No.:BCC1406
CAS No.:732983-37-8
- Deoxynojirimycin hydrochloride
Catalog No.:BCN2626
CAS No.:73285-50-4
- 1,4-Dihydro-1,2-dimethyl-4-oxo-3-quinolinecarboxylic acid
Catalog No.:BCN1369
CAS No.:73281-83-1
- Dehydrobruceine A
Catalog No.:BCN7620
CAS No.:73435-47-9
- 1-Deoxymannojirimycin hydrochloride
Catalog No.:BCC6995
CAS No.:73465-43-7
- Tetrachyrin
Catalog No.:BCN4776
CAS No.:73483-88-2
- 7-Acetyllycopsamine
Catalog No.:BCN2000
CAS No.:73544-48-6
- cis-ACBD
Catalog No.:BCC6587
CAS No.:73550-55-7
- Mevastatin
Catalog No.:BCN2568
CAS No.:73573-88-3
- 27-p-Coumaroyloxyursolic acid
Catalog No.:BCN4288
CAS No.:73584-67-5
- Omeprazole
Catalog No.:BCC1254
CAS No.:73590-58-6
- (-)-Bicuculline methobromide
Catalog No.:BCC6555
CAS No.:73604-30-5
- 3-Hydroxybenzylamine
Catalog No.:BCN1804
CAS No.:73604-31-6
- Xylazine
Catalog No.:BCC5167
CAS No.:7361-61-7
- 1-(4-Methoxycinnamoyl)pyrrole
Catalog No.:BCN4027
CAS No.:736140-70-8
Ex vivo spontaneous generation of 19-norandrostenedione and nandrolone detected in equine plasma and urine.[Pubmed:22051080]
J Steroid Biochem Mol Biol. 2012 Jan;128(1-2):1-11.
19-Norandrostenedione (NAED) and nandrolone are anabolic-androgenic steroids (AASs). Nandrolone was regarded solely as a synthetic AAS until the 1980s when trace concentrations of apparently endogenous nandrolone were detected in urine samples obtained from intact male horses (stallions). Since then, its endogenous origin has been reported in boars and bulls; endogenous NAED and nandrolone have been identified in plasma and urine samples collected from stallions. More recently, however, it was suggested that NAED and nandrolone detected in urine samples from stallions are primarily artifacts due to the analytical procedure. The present study was undertaken to determine whether NAED and nandrolone detected in plasma and urine samples collected from stallions are truly endogenous or artifacts from sample processing. To answer this question, fresh plasma and urine samples from >/=8 stallions were analyzed for the two AASs, soon after collection, by liquid chromatography hyphenated to tandem mass spectrometry (LC-MS/MS). NAED and nandrolone were not detected in fresh plasma samples but detected in the same samples post storage. Concentrations of both AASs increased with storage time, and the increases were greater at a higher storage temperature (37 degrees C versus 4 degrees C, and ambient temperature versus 4 degrees C). Although NAED was detected in some fresh stallion urine samples, its concentration (<407 pg/mL) was far lower (<0.4%) than that in the same samples post storage (at ambient temperature for 15 days). Nandrolone was not detected in most of fresh urine samples but detected in the same samples post storage. Based on these results, it is concluded that all NAED and nandrolone detected in stored plasma samples of stallions and most of them in the stored urine samples are not from endogenous origins but spontaneously generated during sample storage, most likely from spontaneous decarboxylation of androstenedione-19-oic acid and testosterone-19-oic acid. To our knowledge, it is the first time that all NAED and nandrolone detected in plasma of stallions and most of them detected in the urine have been shown to be spontaneously generated in vitro during sample storage. This finding would have significant implications with regard to the regulation of the two steroids in horse racing.
